Artikelen

2021

1. Achterbergh RCA, van Rooijen MS, van den Brink W, Boyd A, de Vries HJC. Enhancing help-seeking behaviour among men who have sex with men at risk for sexually transmitted infections: the syn.bas.in randomised controlled trial. Sex Transm Infect. 2021 Feb;97(1):11-17.
2. Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L, Morris M, Ong JJ, Platt L, Sack-Davis R, van Santen DK, Solomon SS, Sypsa V, Valencia J, Van Den Boom W, Walker JG, Ward Z, Stone J, Vickerman P; Homelessness, HIV, and HCV Review Collaborative Group. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021 Mar 26:S2468-2667(21)00013-X.
3. Basten M, den Daas C, Heijne JCM, Boyd A, Davidovich U, Rozhnova G, Kretzschmar M, Matser A. The Rhythm of Risk: Sexual Behaviour, PrEP Use and HIV Risk Perception Between 1999 and 2018 Among Men Who Have Sex with Men in Amsterdam, The Netherlands. AIDS Behav. 2021; 2021 Jun;25(6):1800-1809.
4. De Scheerder MA, van Bilsen WPH, Dullaers M, Martinez-Picado J, Davidovich U, Vandekerckhove L. Motivations, barries and experiences of participants in an HIV reservoir trial. J Viral Eradication 2021 Jan 23;7:100029
5. de Vries HJC, van der Loeff MFS. Antiseptic mouthwashes against sexually transmitted infections. Lancet Infect Dis. 2021 May;21(5):583-584.
6. Drückler S, Daans C, Hoornenborg E, De Vries H, den Heijer M, Prins M, Kuizenga Wessel S, van Rooijen M. HIV and STI positivity rates among transgender people attending two large STI clinics in the Netherlands. Sex Transm Infect. 2021 Apr 19:sextrans-2020-054875. doi: 10.1136/sextrans-2020-054875. Online ahead of print.
7. Dukers-Muijrers NHTM, Wolffs P, Lucchesi M, Götz HM, De Vries H, Schim van der Loeff M, Bruisten SM, Hoebe CJPA. Oropharyngeal Chlamydia trachomatis in women; spontaneous clearance and cure after treatment (FemCure). Sex Transm Infect. 2021 Mar;97(2):147-151.
8. Enbiale W, Verdonck K, Gebeyehu M, van Griensven J, de Vries HJC. Surgical debulking of podoconiosis nodules and its impact on quality of life in Ethiopia. PLoS Negl Trop Dis. 2021 Jan 22;15(1):e0009053.
9. Hetem DJ, Kuizenga Wessel S, Bruisten SM, Braam JF, van Rooijen MS, Vergunst CE, Nijhuis RH, Berns M, Brand JM, van Dam AP. High prevalence and resistance rates of Mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in the Netherlands. Int J STD AIDS. 2021 Apr 16:956462421999287.
10. Hulstein SH, Matser A, van der Loeff MFS, Hoornenborg E, Prins M, de Vries HJC. Eligibility for HIV pre-exposure prophylaxis (PrEP), intention to use PrEP, and informal use of PrEP among men who have sex with men in Amsterdam, The Netherlands. Sex Transm Dis. 2021 Feb 1;48(2):86-93.
11. Janssen KJH, Wolffs PFG, Hoebe CJPA, Heijman T, Götz HM, Bruisten SM, Schim van der Loeff M, de Vries HJ, Dukers-Muijrers NHTM. Determinants associated with viable genital or rectal Chlamydia trachomatis bacterial load (FemCure). Sex Transm Infect. 2021 Jan 13:sextrans-2020-054533.
12. Jongen VW, van der Loeff MFS, Boyd A, Petrignani M, Prins M, van der Wal M, Nielen A, de Melker H, Paulussen TGWM, Alberts CJ. Human papillomavirus vaccination uptake: a longitudinal study showing ethnic differences in the influence of the intention-to-vaccinate among parent-daughter dyads. Hum Vaccin Immunother. 2021 Apr 3;17(4):990-999.
13. Jongen VW, Schim van der Loeff MF, Botha MH, Sudenga SL, Abrahamsen ME, Giuliano AR. Incidence and risk factors of C. trachomatis and N. gonorrhoeae among young women from the Western Cape, South Africa: The EVRI study. PLoS One. 2021 May 3;16(5):e0250871.
14. Jongen VW, Hoornenborg E, van den Elshout MA, Boyd A, Zimmermann HM, Coyer L, Davidovich U, Anderson PL, de Vries HJ, Prins M, Schim van der Loeff MF; Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam (H-TEAM) Initiative. Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DP. J Int AIDS Soc. 2021 May;24(5):e25708.
15. Jukema JB, Hoenderboom BM, van Benthem BHB, van der Sande MAB, de Vries HJC, Hoebe CJPA, Dukers-Muijrers NHTM, Bax CJ, Morré SA, Ouburg S. Can Previous Associations of Single Nucleotide Polymorphisms in the TLR2, NOD1, CXCR5, and IL10 Genes in the Susceptibility to and Severity of Chlamydia trachomatis Infections Be Confirmed? 2021 Jan 7;10(1):48.
16. Nieuwenburg SA, Sprenger RJ, Schim van der Loeff MF, de Vries HJC. Clinical outcomes of syphilis in HIV-negative and HIV-positive MSM: occurrence of repeat syphilis episodes and non-treponemal serology responses. Sex Transm Infect. 2021 Feb 19:sextrans-2020-054887. doi: 10.1136/sextrans-2020-054887. 
17. Oyen EMM, Maijer KI, van der Bent SAS, Prins JM, Janssen S, Kuipers S, De Vries HJC. Spontaneous resolution of multidrug-resistant Mycobacterium abscessus infection in tattoo. J Eur Acad Dermatol Venereol. 2021 May;35(5):e328-e330.
18. Reyniers T, Zimmermann HML, Davidovich U, Vuylsteke B, Laga M, Hoornenborg E, Prins M, de Vries HJC, Nöstlinger C. The social meanings of PrEP use – A mixed-method study of PrEP use disclosure in Antwerp and Amsterdam. Sociol Health Illn. Apr 2021;00:1-17.
19. Schellekens MHFT, Stegeman H, van der Wal WF, van Rijn RC, Nielen AMA, Schim van der Loeff MF. Redenen om niet te vaccineren in Amsterdam en Amstelland. Tijdschrift Jeugdgezondheidszorg 2021:1-6.
20. Slurink I, van Aar F, Parkkali S, Heijman T, Götz H, Kampman K, van Weert Y, van Benthem B, van de Laar T, Op de Coul E. Recently acquired HIV infections and associated factors among men who have sex with men diagnosed at Dutch sexual health centres. Int J STD AIDS. 2021 Apr 28:9564624211008071.
21. Stam A, Hoornenborg E. Hiv Pre-expositie profylaxe (PrEP). Ned Tijdschr Med Microbiol 2021;29:1:9-17.
22. van Bilsen WPH, van Dulm E, Matser DA, Linde I, van Duijnhoven DYTHP, Prins PJM, Prins PM, Boyd DA, van Dam DAP. High carriage of ESBL-producing Enterobacteriaceae associated with sexual activity among men who have sex with men. Int J Antimicrob Agents. 2021 Jan 9:106276.
23. van Bilsen WPH, Zimmermann HML, Boyd A, Coyer L, van der Hoek L, Kootstra NA, Hoornenborg E, Prins M, Schim van der Loeff MF, Davidovich U, Matser A. Sexual Behavior and Its Determinants During COVID-19 Restrictions Among Men Who Have Sex With Men in Amsterdam. J Acquir Immune Defic Syndr. 2021 Mar 1;86(3):288-296.
24. van Wifferen F, Hoornenborg E, Schim van der Loeff MF, Heijne J, van Hoek AJ. Cost-effectiveness of two screening strategies for Chlamydia trachomatis and Neisseria gonorrhoeae as part of the PrEP programme in the Netherlands: a modelling study. Sex Transm Infect. 2021 Jan 11:sextrans-2020-054741.
25. Verboeket SO, Boyd A, Wit FW, Verheij E, Schim van der Loeff MF, Kootstra N, van der Valk M, van Steenwijk RP, Drummond MB, Kirk GD, Reiss P, on behalf of the AGEhIV Cohort Study. Changes in lung function among treated HIV-positive and HIV-negative individuals: analysis of the prospective AGEhIV cohort study. Lancet Health Longevity 2021 apr;2:e202-11.
26. Verheij E, Wit FW, Verboeket SO, Schim van der Loeff MF, Nellen JF, Reiss P, Kirk GD. Frequency, Risk Factors, and Mediators of Frailty Transitions During Long-Term Follow-Up Among People With HIV and HIV-Negative AGEhIV Cohort Participants. J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):110-118.
27. Vujkovic-Cvijin I, Sortino O, Verheij E, Wit FW, Kootstra NA, Sellers B, Schim van der Loeff M, Belkaid Y, Reiss P, Sereti I. The complement pathway is activated in people with HIV and is associated with non-AIDS comorbidities. J Infect Dis. 2021 Feb 19
28. Zimmermann HML, Postma LR, Achterbergh RCA, Reyniers T, Schim van der Loeff MF, Prins M, de Vries HJC, Hoornenborg E, Davidovich U; Amsterdam PrEP Project Team in the HIV Transmission Elimination Amsterdam Initiative (H-TEAM). The Impact of Pre-exposure Prophylaxis on Sexual Well-Being Among Men Who Have Sex with Men. Arch Sex Behav. 2021 Feb 22.

2020

1. R.C.A. Achterbergh, S. Drückler, M.S. van Rooijen, F. van Aar, I.A.L. Slurink, H.J.C. de Vries, A. Boyd. Sex, drugs, and sexually transmitted infections : a latent class analysis among men who have sex with men in Amsterdam and surrounding urban regions, the Netherlands.  Drug and Alcohol Dependence; volume 206 (2020) , 9 p.
2. Achterbergh RCA, de Vries HJC, Boyd A, Davidovich U, Drückler S, Hoornenborg E, Prins M, Matser A. Identification and characterization of latent classes based on drug use among men who have sex with men at risk of sexually transmitted infections in Amsterdam, the Netherlands. Addiction. 2020 Jan;115(1):121-133.
3. Achterbergh RCA, Drückler S, van Rooijen MS, van Aar F, Slurink IAL, de Vries HJC, Boyd A. Sex, drugs, and sexually transmitted infections: A latent class analysis among men who have sex with men in Amsterdam and surrounding urban regions, the Netherlands. Drug Alcohol Depend. 2020 Jan 1;206:107526.
4. Achterbergh RCA, van Rooijen MS, van den Brink W, Boyd A, de Vries HJC. Enhancing help-seeking behaviour among men who have sex with men at risk for sexually transmitted infections: the syn.bas.in randomised controlled trial. Sex Transm Infect. 2020 Jul 31.
5. Achterbergh RCA, Hoornenborg E, Boyd A, Coyer L, Meuzelaar SJA, Hogewoning AA, Davidovich U, van Rooijen MS, Schim van der Loeff MF, Prins M., de Vries HJC. Changes in mental health and drug use among men who have sex with men using daily and event-driven pre-exposure prophylaxis: Results from a prospective demonstration project in Amsterdam, the Netherlands EClinicalMedicine. 2020 Sep; 26: 100505.
6. Alberts CJ, Jeske R, de Martel C, den Hollander WJ, Michel A, Prins M, Snijder MB, Schim van der Loeff MF, Waterboer T. Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS study. 2020 Jun;25(3):e12687.
7. Baas M, Beers E, van Dam AP, van Bergen JE. Who cares for syphilis? A cross-sectional study on diagnosis and treatment of syphilis by GPs in Amsterdam, the Netherlands. BJGP Open. 2020 Jun 23;4(2): bjgpopen20X101027.
8. Basten M, den Daas C, Heijne JCM, Boyd A, Davidovich U, Rozhnova G, Kretzschmar M, Matser A. The Rhythm of Risk: Sexual Behaviour, PrEP Use and HIV Risk Perception Between 1999 and 2018 Among Men Who Have Sex with Men in Amsterdam, The Netherlands. AIDS Behav. 2020 Dec 2.
9. Boender TS, Op de Coul E, Arends J, Prins M, van der Valk M, van der Meer JTM, van Benthem B, Reiss P, Smit C. Acute hepatitis C infection among adults with HIV in the Netherlands between 2003 and 2016: a capture-recapture analysis for the 2013 to 2016 period. Euro Surveill. 2020 Feb;25(7)
10. Bogers SJ, Schim van der Loeff MF, van Dijk N, Groen K, Groot Bruinderink ML, de Bree GJ, Reiss P, Geerlings SE, van Bergen JEAM. Rationale, design and initial results of an educational intervention to improve provider-initiated HIV testing in primary care. Fam Pract. 2020 Dec 26:cmaa139
11. Braam JF, Hetem DJ, Vergunst CE, Kuizenga Wessel S, van Rooijen MS, Nijhuis RHT, Schim van der Loeff MF, van Dam AP, Bruisten SM. Evaluating the prevalence and risk factors for macrolide resistance in Mycoplasma genitalium using a newly developed qPCR assay. PLoS One. 2020 Oct 20;15(10):e0240836.
12. Coyer L, Njoya O, Njouom R, Mossus T, Kowo MP, Essomba F, Boers A, Coutinho R, Ondoa PO, and on behalf of the HEP-C-IMPACT Team. Achieving a high cure rate with direct-acting antivirals for chronich hepatitis C virus infection in Cameroon: a multi-clinic demonstration project. Tropical Med and Intern Health 2020
13. Coyer L, van den Elshout MAM, Achterbergh RCA, Matser A, Schim van der Loeff MF, Davidovich U, de Vries HJC, Prins M, Hoornenborg E, Boyd A; Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam (H-TEAM) Initiative. Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men. The Lancet. 2020 Dec 1;29-30:100650.
14. de Korne-Elenbaas J, Pol A, Vet J, Dierdorp M, van Dam AP, Bruisten SM. Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics. Sex Transm Dis. 2020 Apr;47(4):238-242.
15. Dijkstra M, Lin TC, de Bree GJ, Hoenigl M, Schim van der Loeff MF. Validation of the San Diego Early Test Score for Early Human Immunodeficiency Virus Infection Among Amsterdam Men Who Have Sex With Men. Clin Infect Dis. 2020 May 6;70(10):2228-2230.
16. Dijkstra M, van Rooijen MS, Hillebregt MM, van Sighem A, Smit C, Hogewoning A, Davidovich U, Heijman T, Hoornenborg E, Reiss P, van der Valk M, Prins M, Prins JM, Schim van der Loeff MF, de Bree GJ. Decreased time to viral suppression after implementation of targeted testing and immediate initiation of treatment of acute HIV infection among men who have sex with men in Amsterdam. Clin Infect Dis. 2020 May 5:ciaa505.
17. Doyle JS, van Santen DK, Iser D, Sasadeusz J, O’Reilly M, Harney B, Traeger MW, Roney J, Cutts JC, Bowring AL, Winter R, Medland N, Fairley CK, Moore R, Tee B, Asselin J, El-Hayek C, Hoy JF, Matthews GV, Prins M, Stoové MA, Hellard ME. Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial. Clin Infect Dis. 2020 Oct 3:ciaa1500.
18. Drückler S, van Rooijen MS, de Vries HJC. Substance Use and Sexual Risk Behavior Among Male and Transgender Women Sex Workers at the Prostitution Outreach Center in Amsterdam, the Netherlands. Sex Transm Dis. 2020 Feb;47(2):114-121.
19. Dukers-Muijrers NHTM, Heijman T, Götz HM, Zaandam P, Wijers J, Leenen J, van Liere G, Heil J, Brinkhues S, Wielemaker A, Schim van der Loeff MF, Wolffs PFG, Bruisten SM, Steenbakkers M, Hogewoning AA, de Vries HJ, Hoebe CJPA. Participation, retention, and associated factors of women in a prospective multicenter study on Chlamydia trachomatis infections (FemCure). PLoS One. 2020 Mar 18;15(3):e0230413
20. Dukers-Muijrers NHTM, Janssen KJH, Hoebe CJPA, Götz HM, Schim van der Loeff MF, de Vries HJC, Bruisten SM, Wolffs PFG. Spontaneous clearance of Chlamydia trachomatis accounting for bacterial viability in vaginally or rectally infected women (FemCure). Sex Transm Infect. 2020 Nov;96(7):541-548.
21. Edridge AWD, Kaczorowska J, Hoste ACR, Bakker M, Klein M, Loens K, Jebbink MF, Matser A, Kinsella CM, Rueda P, Ieven M, Goossens H, Prins M, Sastre P, Deijs M, van der Hoek L. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020 Sep 14.
22. Enbiale W, Baynie TB, Ayalew A, Gebrehiwot T, Getanew T, Ayal A, Ayalew M, De Vries HJ, Takarinda K, Manzi M, Zachriah R. “Stopping the itch”: mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia. J Infect Dev Ctries. 2020 Jun 29;14(6.1):28S-35S.
23. European Treatment Network for HIV, Hepatitis and Global Infectious Diseases (NEAT-ID) Consensus Panel. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases consensus panel. AIDS. 2020 Oct 1;34(12):1699-1711.
24. Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L; International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3) Collaborative. Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Clin Infect Dis. 2020 Jan 1;70(1):123-131.
25. Hoenderboom BM, van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, de Vries HJC, van den Broek IVF, de Vries F, Land JA, van der Sande MAB, Morré SA, van Benthem BHB. Pregnancies and time to pregnancy in women with and without a previous Chlamydia trachomatis infection. Sex Transm Dis. 2020 Nov;47(11):739-747.
26. Hoornenborg E, Coyer L, Boyd A, Achterbergh RCA, Schim van der Loeff MF, Bruisten S, de Vries HJC, Koopsen J, van de Laar TJW, Prins M; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative. High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis. J Hepatol. 2020 May;72(5):855-864.
27. Jongen VW, Richel O, Marra E, Siegenbeek van Heukelom ML, van Eeden A, de Vries HJC, Cairo I, Prins JM, Schim van der Loeff MF. Anal Squamous Intraepithelial Lesions (SILs) in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men: Incidence and Risk Factors of SIL and of Progression and Clearance of Low-Grade SILs. J Infect Dis. 2020 Jun 16;222(1):62-73.
28. Jongen VW, van Rooijen MS, Schim van der Loeff MF, Newsum AM, de Vos Klootwijk L, Hoornenborg E, Hogewoning A, van der Valk M, van den Berk GEL, Prins M, Heijman T. Evaluation of the hepatitis C testing strategy for HIV-positive men who have sex with men at the sexually transmitted infections outpatient clinic of Amsterdam, the Netherlands. Sex Transm Dis. 2020 Sep;47(9):587-595.
29. Knox J, Boyd A, Matser A, Heijman T, Sandfort T, Davidovich U. Types of Group Sex and Their Association with Different Sexual Risk Behaviors Among HIV-Negative Men Who Have Sex with Men. Arch Sex Behav. 2020 Aug;49(6):1995-2003.
30. Koopsen J, Parker E, Han AX, van de Laar T, Russell C, Hoornenborg E, Prins M, van der Valk M, Schinkel J. HCV transmission among MSM in Amsterdam: external introductions may complicate micro-elimination efforts. Clin Infect Dis. 2020 Dec 8:ciaa1830.
31. Kruize Z, Maurer I, van Dort KA, van den Elshout MAM, Hoornenborg E, Booiman T, Prins M, Kootstra NA. Human Immunodeficiency Virus-Negative Men Who Have Sex With Men Have an Altered T-Cell Phenotype and Bioenergy Metabolism. Open Forum Infect Dis. 2020 Jul 5;7(8):ofaa284.
32. Leeman A, Jenkins D, Marra E, van Zummeren M, Pirog EC, van de Sandt MM, van Eeden A, Schim van der Loeff MF, Doorbar J, de Vries HJC, van Kemenade FJ, Meijer CJLM, Quint WGV. Grading immunohistochemical markers p16 INK4a and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions. Br J Dermatol. 2020 Apr;182(4):1026-1033.
33. Martinez L, Cords O, Horsburgh CR, Andrews JR; Pediatric TB Contact Studies Consortium. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet. 2020 Mar 21;395(10228):973-984.
34. Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, Kootstra NA, Prins M, Ball JK, Bakker AQ, de Jong MD, Spits H, Beaumont T, Schinkel J. Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’ (J Hepatol 2019; 71(1): 14-24). J Hepatol. 2020 Oct;73(4):999-1000.
35. Newsum AM, Matser A, Schinkel J, van der Valk M, Brinkman K, van Eeden A, Lauw FN, Rijnders BJA, van de Laar TJW, van de Kerkhof M, Smit C, Boyd A, Arends JE, Prins M. Incidence of HCV reinfection among HIV-positive MSM and its association. Clin Infect Dis. 2020 May 27:ciaa645.
36. Op de Coul E, den Daas C, Spijker R, Heijman T, de Vos M, Götz H, Vermey K, Zuilhof W, Van den Boogaard J, Davidovich U, Zuure F; PREVENT Collaborators. Web-Supported Social Network Testing for HIV Among Men Who Have Sex With Men With a Migration Background: Protocol for a Mixed Methods Pilot Study. JMIR Res Protoc. 2020 Feb 9;9(2):e14743. doi: 10.2196/14743.
37. Overbosch F, de Boer M, Veldkamp KE, Ellerbroek P, Bleeker-Rovers CP, Goorhuis B, van Vugt M, van der Eijk A, Leenstra T, Khargi M, Ros J, Brandwagt D, Haverkate M, Swaan C, Reusken C, Timen A, Koopmans M, van Dissel J, The Lassa fever response team of the Netherlands. Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019. Euro Surveill. 2020 Apr;25(15):2000265.
38. Oyen EMM, Maijer KI, van der Bent SAS, Prins JM, Janssen S, Kuipers S, De Vries HJC. Spontaneous resolution of multidrug-resistant Mycobacterium abscessus infection in tattoo. J Eur Acad Dermatol Venereol. 2020 Dec 8.
39. Palmer S, Dijkstra M, Ket JCV, Wahome EW, Walimbwa J, Gichuru E, van der Elst EM, Schim van der Loeff MF, de Bree GJ, Sanders EJ. Acute and early HIV infection screening among men who have sex with men, a systematic review and meta-analysis. JIAS 2020 Oct;23 Suppl 6(Suppl 6):e25590.
40. Prinsenberg T, Rebers S, Boyd A, Zuure F, Prins M, van der Valk M, Schinkel J. Dried blood spot self-sampling at home is a feasible technique for hepatitis C RNA detection. PLoS One. 2020 Apr 14;15(4):e0231385.
41. Prinsenberg T, Zantkuijl P, Zuilhof W, Davidovich U, Schinkel J, Prins M, van der Valk M. Design and implementation of a multilevel intervention to reduce hepatitis C transmission among men who have sex with men in Amsterdam: co-creation and usability study. JMir Form Res 2020;4:9.
42. Reitsema M, Hoek AJV, van der Loeff MS, Hoornenborg E, van Sighem A, Wallinga J, van Benthem B, Xiridou M. Preexposure prophylaxis for men who have sex with men in the Netherlands: impact on HIV and Neisseria gonorrhoeae transmission and cost-effectiveness. AIDS. 2020 Mar 15;34(4):621-630.
43. Sacks-Davis R, van Santen DK, Doyle JS. Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era. Addiction. 2020 Mar;115(3):583-584.
44. Safreed-Harmon K, Kall M, Anderson J, Azzopardi-Muscat N, Behrens GMN, d’Arminio Monforte A, Davidovich U, Noori T, Lazarus JV. Ability to Monitor National Responses to the HIV Epidemic “Beyond Viral Suppression”: Findings From Six European Countries. Front Public Health. 2020 Mar 20;8:36.
45. Schim van der Loeff MF, Vorsters A, Marra E, Van Damme P, Hogewoning A. Letter to the editor: female sex workers and HPV vaccine. Hum Vaccin Immunother. 2020;16(1):126-127.
46. Slurink IAL, van Benthem BHB, van Rooijen MS, Achterbergh RCA, van Aar F. Latent classes of sexual risk and corresponding STI and HIV positivity among MSM attending centres for sexual health in the Netherlands. Sex Transm Infect. 2020 Feb;96(1):33-39.
47. Slurink I, Groen K, Gotz HM, Meima A, Kroone MM, Hogewoning AA, Ott A, Niessen W, Dukers-Muijers N, Hoebe C, Koedijk F, Kampman C, van Bergen J. Contribution of general practitioners and sexual health centres to sexually transmitted infection consultations in five Dutch regions using laboratory data of Chlamydia trachomatis testing. Int J STD AIDS. 2020 May;31(6):517-525.
48. Smit PW, Cornelissen AR, Bruisten SM. Reduction of non-typeable results using a plasmid oriented Lymfogranuloma venereum PCR for typing of Chlamydia trachomatis positive samples. PLoS One. 2020 Jun 4;15(6):e0233990.
49. van Aar F, Kroone MM, de Vries HJ, Götz HM, van Benthem BH. Increasing trends of lymphogranuloma venereum among HIV-negative and asymptomatic men who have sex with men, the Netherlands, 2011 to 2017. Euro Surveill. 2020 Apr;25(14):1900377.
50. van Bilsen WPH, Boyd A, van der Loeff MFS, Davidovich U, Hogewoning A, van der Hoek L, Prins M, Matser A. Diverging trends in incidence of HIV versus other sexually transmitted infections in HIV-negative MSM in Amsterdam. AIDS. 2020 Feb 1;34(2):301-309.
51. van Bilsen WPH, Zimmermann HML, Boyd A, Davidovich U; HIV Transmission Elimination Amsterdam Initiative. Burden of living with HIV among men who have sex with men: a mixed-methods study. Lancet HIV. 2020 Oct 8:S2352-3018(20)30197-1.
52. van der Zee RP, Richel O, van Noesel CJM, Ciocănea-Teodorescu I, van Splunter AP, Ter Braak TJ, Nathan M, Cuming T, Sheaff M, Kreuter A, Meijer CJLM, Quint WGV, de Vries HJC, Prins JM, Steenbergen RDM. Cancer risk stratification of anal intraepithelial neoplasia in HIV-positive men by validated methylation markers associated with progression to cancer Clin Infect Dis. 2020 Apr 8:ciaa397.
53. van Dulm E, van der Veldt W, Jansen-van der Meiden K, van Renselaar G, Bovée L, Ros J, Davidovich U, van Duijnhoven Y. Correction to: Perceived barriers and enablers for preventing the spread of carbapenemase-producing gram-negative bacteria during patient transfers: a mixed methods study among healthcare providers. BMC Infect Dis. 2020; 20: 70. Published online 2020 Jan 22.
54. van Dulm E, Marra E, Kroone MM, van Dijk AE, Hogewoning AA, Schim van der Loeff MF. Sexually transmissible infections among female sex workers in Amsterdam between 2011 and 2016: does risk vary by work location? Sex Health. 2020 Aug;17(4):368-376.
55. van Dulm E, Klok S, Boyd A, Joore IK, Prins M, van Dam AP, Tramper-Stranders GA, van Duijnhoven YTHP. Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) among 5 undocumented migrants and uninsured legal residents in Amsterdam, the Netherlands: a cross-sectional study. Antimicrob Resist Infect Control. 2020 Jul 29;9(1):118.
56. van Santen DK, Boyd A, Bruisten S, Sonder GJ, Prins M, van Houdt R. Frequent delayed spontaneous seroclearance of hepatitis B virus after incident HBV infection among adult high-risk groups. J Viral Hepat. 2020 Jan;27(1):81-87.
57. van Santen DK, Sacks-Davis R, Hellard M. Hepatitis C elimination in people living with HIV – the importance of biomedical and behavioural interventions. J Int AIDS Soc. 2020 Jul;23(7):e25589.
58. van Santen DK, Sacks-Davis R, Doyle JS, Scott N, Prins M, Hellard M. Measuring hepatitis C virus elimination as a public health threat: Beyond global targets. J Viral Hepat. 2020 Aug;27(8):770-773.
59. Verboeket SO, Wit FW, Verheij E, van Zoest RA, Kootstra NA, van der Valk M, Prins JM, Schim van der Loeff MF, Reiss P. HIV-negative Men Who Have Sex with Men have higher CD8+ T-cell Counts and Lower CD4+/CD8+ T-cell Ratios compared to HIV-negative Heterosexual Men. J Infect Dis. 2020 Jan 31.
60. Verheij E, Kirk GD, Wit FW, van Zoest RA, Verboeket SO, Lemkes BA, Schim van der Loeff MF, Reiss P. Frailty is associated with mortality and incident comorbidity among middle-aged HIV-positive and HIV-negative participants. J Infect Dis. 2020 Jan 20.
61. Vujkovic-Cvijin I, Sortino O, Verheij E, Sklar J, Wit FW, Kootstra NA, Sellers B, Brenchley JM, Ananworanich J, Schim van der Loeff M, Belkaid Y, Reiss P, Sereti I. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases Nat Commun. 2020 May 15;11(1):2448.
62. Wahome EW, Graham SM, Thiong’o AN, Mohamed K, Oduor T, Gichuru E, Mwambi J, Prins M, van der Elst E, Sanders PEJ. PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men. EClinicalMedicine. 2020 Sep 9;26:100541.
63. Zimmermann HML, Jongen VW, Boyd A, Hoornenborg E, Prins M, de Vries HJC, Schim van der Loeff MF, Davidovich U; Amsterdam PrEP Project Team in the HIV Transmission Elimination Amsterdam Initiative (H-TEAM). Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands. AIDS. 2020 Dec 1;34(15): 2295-2304.
64. Zondag HCA, Bruisten SM, Vrbová E, Šmajs D. No bejel among Surinamese, Antillean and Dutch syphilis diagnosed patients in Amsterdam between 2006-2018 evidenced by multi-locus sequence typing of Treponema pallidum isolates. PLoS One. 2020 Mar 11;15(3):e0230288

2019

1. Aarab, S.J.H. Vijverberg, M. Prins, M.B. Snijder, [et al.]. Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study. Respiratory Medicine; volume (2019), p. 113-119
2. A. Abayasingam, P. Leung, A. Elthala, M. Prins, [et al.]. Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing. Infection, Genetics and Evolution; volume 71 (2019), p. 36-41
3. C.J. Alberts, A. Boyd, S.M. Bruisten, T. Heijman, A. Hogewoning, M. van Rooijen, E. Siedenburg, G.J.B. Sonder. Hepatitis A incidence, seroprevalence, and vaccination decision among MSM in Amsterdam, the Netherlands. Vaccine; volume 37 (2019), p. 2849-2856
4. A.A. Anas, J.M. Prins, N. Bode, H.J.C. de Vries, S. Middeldorp, M.P. Grobusch. Fever and a rapidly progressive skin ulcer after a visit to Morocco : a diagnostic challenge. Travel Medicine and Infectious Disease, 2 p
5. W.P.H. van Bilsen, H.L. Zaaijer, A. Matser, K. van den Hurk, E. Slot, M.F. Schim van der Loeff, M. Prins, T.J.W. van de Laar. Infection pressure in men who have sex with men and their suitability to donate blood. Clinical Infectious Diseases; volume 68 (2019), p. 1001-1008
6. W.P.H. van Bilsen, A. Kovaleva, M.C.G. Bleeker, A.J. King, S.M. Bruisten, W. Brokking, H.J.C. de Vries, C.J.L.M. Meijer, M.F. Schim van der Loeff. HPV infections and flat penile lesions of the penis in men who have sex with men. Papillomavirus Research; volume 8 (2019), 5 p.
7. J.A. Bogaards, S.H. Mooij, M. Xiridou, M.F. Schim van der Loeff. Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands : a multi-model approach. PLOS Medicine; volume 16 (2019), p. e1002756
8. R.J.M. Born, K. van der Linden, A. Matser, N. Poulin, M.F. Schim van der Loeff, B.H.W. Bakker, T.F. van Boven. The effects of free condom distribution on HIV and other sexually transmitted infections in men who have sex with men. BMC Infectious Diseases; volume 19 (2019), 10 p.
9. F. Dias Goncalves Lima, J.D. Viset, M.M.G. Leeflang, J. Limpens, J.M. Prins, H.J.C. de Vries. The Accuracy of Anal Swab-Based Tests to Detect High-Grade Anal Intraepithelial Neoplasia in HIV-Infected Patients: A Systematic Review and Meta-analysis. Open Forum Infectious Diseases; volume 6 (2019), 8 p.
10. N.H.T.M. Dukers-Muijrers, H. de Vries, T. Heijman, S.M. Bruisten, A. Hogewoning, M.F. Schim van der Loeff, [et al.]. Treatment effectiveness of azithromycin and doxycycline in uncomplicated rectal and vaginal Chlamydia trachomatis infections in women : a multicentre observational study (FemCure). Clinical Infectious Diseases; volume 69 (2019), p. 1946–1954
11. N.H.T.M. Dukers-Muijrers, P.F.G. Wolffs, H.J.C. de Vries, H.M. Götz, K. Janssen, C.J.P.A. Hoebe. Viable bacterial load is key to azithromycin treatment failure in rectally chlamydia trachomatis infected women (FemCure). Journal of Infectious Diseases; volume 220 (2019), p. 1389–1390
12. E. van Dulm, M.S. van Rooijen, P. Oostvogel, [et al.]. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands. Plos One; volume 14 (2019), 14 p
13. E. van Dulm, W. van der Veldt, K. Jansen-van der Meiden, G. van Renselaar, L. Bovée, J. Ros, U. Davidovich, Y.T.H.P. van Duijnhoven. Perceived barriers and enablers for preventing the spread of carbapenem producing gram-negative bacteria during patient transfers : a mixed methods study among healthcare providers. BMC Infectious Diseases; volume 19 nr. 1050 (2019), p. 12 p.
14. R.N.N. Finkenflügel, E. Hoornenborg, R.C.A. Achterbergh, E. Marra,
    U. Davidovich, H.J.C. de Vries, M. Prins, M.F. Schim van der Loeff.
    A mobile application to collect daily data on preexposure prophylaxis adherence and sexual behavior among men who have sex with men : use over time and comparability with conventional data collection.
    Sexually Transmitted Diseases; volume 46 (2019), p.  400-406
15. J.J. van der Helm, M.F. Schim van der Loeff, E. de Vries, C. van
    der Veer, H.J.C. de Vries, [et al.]. Vaginal herb use and chlamydia trachomatis infection : cross-sectional study among women of various ethnic groups in Suriname. BMJ Open; volume 9 (2019), p. e025417
16. E. Hoornenborg, L. Coyer, R.C.A. Achterbergh, A. Matser, M.F. Schim
    van der Loeff, A. Boyd, Y.T.H.P. van Duijnhoven, S.M. Bruisten, P.
    Oostvogel, U. Davidovich, A. Hogewoning, M. Prins, H.J.C. de Vries.  Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP : 2 year results from a demonstration study. The Lancent HIV; volume 6 (2019), p. e447-e455
17. V.W. Jongen, D.K. van Santen, C.J. Alberts, M.F. Schim van der
    Loeff. Estimating incidence rates of grouped HPV types : a systematic review and comparison of the impact of different epidemiological assumptions. Papillomavirus Research; volume 8 (2019), p. 15
18. J. Koopsen, J.E. van Steenbergen, J.H. Richardus, M. Prins, E.L.M.
    op de Coul, E.A. Croes, J. Heil, F.R. Zuure, I.K. Veldhuijzen. Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population. Epidemiology and Infection; volume 147 (2019), p. 8 p.
19. A. Leeman, D. Jenkins, E. Marra, M.F. Schim van der Loeff, H.J.C.
    de Vries, [et al.]. Grading immunohistochemical markers p16 INK4a and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions. British Journal of Dermatology; (2019), p. 20 p.
20. J. Leenen, G.A.F.S. van Liere, C.J.P.A. Hoebe, A.A. Hogewoning,
    H.J.C. de Vries, N.H.T.M. Dukers-Muijrers. A longitudinal study to
    investigate previous Chlamydia trachomatis infection as a risk
    factor for subsequent anorectal infection in men who have sex with
    men (MSM) and women visiting STI clinics in the Netherlands.
    Epidemiology and Infection; volume 147 (2019), p. e214
21. C. Lin, J. Slama, M.F. Schim van der Loeff, [et al.] Cervical determinants of anal HPVinfection and high-grade anal lesions in women: a collaborative
    pooled analysis. The Lancet; volume 19 (2019), p. 880-891
22. E. Marra, M.L. Siegenbeek van Heukelom, H.J.C. de Vries, M.F. Schim
    van der Loeff, [et al.]. Virological and serological predictors of anal high-grade squamous intraepithelial lesions among human immunodeficiency virus-positive men who have sex with men. Clinical Infectious Diseases; volume 68 (2019), p. 1377-1387
23. K.H. Mayer, H.J.C. de Vries. HIV and sexually transmitted infections:
    reconciling estranged bedfellows in the U = U and PrEP era. Journal of the International Aids Society; volume 22 (2019), p. e25357
24. A.M. Newsum, K.W. Kooij, A. Boyd, C. Smit, F.W.N.M. Wit, J.T.M. van
    der Meer, M. Prins, P. Reiss, M. van der Valk. Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM. AIDS; volume 33 (2019), p. 833-844
25. B.M. Nijmeijer, J. Koopsen, J. Schinkel, M. Prins, T.B.H.
    Geijtenbeek. Sexually transmitted hepatitis C virus infections : current trends, and recent advances in understanding the spread in men who have sex with men. Journal of the International Aids Society; volume 22
    (2019), p. e25348
26. F.W. Overbosch, F. Elfrink, J. Schinkel, G.J.B. Sonder. No chikungunya virus infections among Dutch long-term travellers to (sub)tropical countries: a prospective study 2008–2011. BMC Infectious Diseases; volume 19 nr. 196 (2019), 5 p.
27. M. Reitsema, L. Steffers, M. Visser, M.F. Schim van der Loeff, [et
    al.]. Cost-effectiveness of increased HIV testing among MSM in The
    Netherlands. AIDS; volume 33 (2019), p. 1807–1817
28. M. Reitsema, J. Heijne, M. Visser, M.F. Schim van der Loeff, [et
    al.]. Impact of frequent testing on the transmission of HIV and N. gonorrhoeae among men who have sex with men : a mathematical modelling study. Sexually Transmitted Infections; (2019), 7 p.
29. K. Safreed-Harmon, J. Anderson, A. d’ Arminio Monforte, U.
    Davidovich, [et al.]. Reorienting health systems to care for people with HIV beyond viral suppression. The Lancet HIV; volume 6 (2019), p. e869-e877
30. D.K. van Santen, J.J. van der Helm, M. Prins, R.B. Geskus, [et al.]. Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.
    AIDS; volume 33 (2019), p. 327-337
31. M.F. Schim van der Loeff, A. Vorsters, E. Marra, P. van Damme, A.
    Hogewoning. Letter to the editor : female sex workers and HPV vaccine.
    Human Vaccines & Immunotherapeutics; (2019), 3 p.
32. M.F. Schim van der Loeff, A. Vorsters, E. Marra, P. Van Damme, A.
    Hogewoning. Should female sex workers be offered HPV vaccination?
    Human Vaccines & Immunotherapeutics; (2019), 5 p.
33. E.C. Schuts, E. van Dulm, A. Boyd, M.B. Snijder, S.E. Geerlings, M.
    Prins, J.M. Prins. Knowledge and use of antibiotics in six ethnic groups: the HELIUS study. Antimicrobial Resistance and Infection Control; volume 8 (2019), 17 p.
34. P.W. Smit, T. Heijman, M. El Abdallaoui, S.M. Bruisten. Comparison of collection methods for molecular detection of a-herpes viruses and Treponema pallidum, including evaluation of critical transportation conditions. Heliyon; volume 5 (2019), p. e01522.
35. C. van der Veer, R.Y. Hertzberger, S.M. Bruisten, H.J.C. de Vries,
    [et al.]. Comparative genomics of human Lactobacillus crispatus isolates reveals genes for glycosylation and glycogen degradation: implications for in vivo dominance of the vaginal microbiota. Microbiome; volume 7 (2019), 14 p.
36. C. van der Veer, S.M. Bruisten, R. van Houdt, A.A. Matser, G.
    Tachedjian, J.H.H.M. van de Wijgert, H.J.C. de Vries, J.J. van der
    Helm. Effects of an over-the-counter lactic-acid containing intra-vaginal douching product on the vaginal microbiota. BMC Microbiology; volume 19 (2019), 13 p.
37. H.J.C. de Vries. Lymphoganuloma venereum in the Western world, 15 years after its re-emergence: new perspectives and research priorities.
    Current Opinion in Infectious Diseases; volume 32 (2019), p. 43-50
38. H.J.C. de Vries, B. de Barbeyrac, N.H.N. de Vrieze, J.D. Viset,
    J.A. White, M. Vall-Mayans, M. Unemo. 2019 European guideline on the management of lymphogranuloma venereum. Journal of the European Academy of Dermatology and Venereology; volume 33 (2019), p. 1821-1828
39. H.J.C. de Vries, M.F. Schim van der Loeff. Solithromycin for the treatment of drug-resistant gonorrhoea. The Lancet Infectious Diseases; (2019), 2 p.
40. D.A. van Wees, J.C.M. Heijne, T. Heijman, K.C.J.G. Kampman, K.
    Westra, A. de Vries, J. de Wit, M.E.E. Kretzschmar, C. den Daas. A multidimensional approach to assessing infectious disease risk : identifying risk classes based on psychological characteristics.
    American Journal of Epidemiology; (2019), p. 21 p.
41. H.M.L. Zimmermann, S.W. Eekman, R.C.A. Achterbergh, M.F. Schim van
    der Loeff, M. Prins, H.J.C. de Vries, E. Hoornenborg, U. Davidovich. Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis – a qualitative analysis. Journal of the International Aids Society; volume 22 (2019), p. e25389
42. F.R. Zuure, J.P. Bil, M. Visser, M.B. Snijder, A. Boyd, P.R. Blom,
    G.J.B. Sonder, J. Schinkel, M. Prins. Hepatitis B and C screening needs among different ethnic groups: a population-based study in Amsterdam, the Netherlands. JHEP Reports; volume 1(2019), p. 71-80
43. J.M. Zwart, M.J.J. Mangen, M. Bartelsman, M.S. van Rooijen, H.J.C.
    de Vries, M. Xiridou. Microscopic examination of Gram-stained smears for anogenital gonorrhoea in men who have sex with men is cost-effective: evidence from a modelling study. Sexually Transmitted Infections; volume 95 (2019), p. 13-20
44. J.M. Zwart, M.J.J. Mangen, M. Bartelsman, M.S. van Rooijen, H.J.C. de Vries, M. Xiridou. Microscopic examination of Gram-stained smears for anogenital gonorrhoea in men who have sex with men is cost-effective: evidence from a modelling study. Sexually Transmitted Infections; volume 95 (2019), p. 13-20

2018

1. C.J. Alberts, M.F. Schim van der Loeff, S. Sadik, F.R. Zuure, E.J.A.J. Beune, M. Prins, M.B. Snijder, S.M. Bruisten. Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands. PLoS ONE 13 nr. 12 (2018), e0208522
2. M. Bartelsman, K. Vaughan, M.S. van Rooijen, H.J.C. de Vries, M. Xiridou . Impact of point-of care management on the transmission of anogenital gonococcal infections among men who have sex with men in Amsterdam: a mathematical modelling and cost-effectiveness study. Sexually Transmitted Infections; volume 94 nr. 3 (2018), 174-179
3. J.E.A.M. van Bergen, H.J.C. de Vries, B.H.B. van Benthem. Epidemiologie van seksueel overdraagbare infecties : hoe moeten we de Nederlandse cijfers duiden?. Nederlands Tijdschrift voor Geneeskunde (NTVG); volume 162 nr. D2736 (2018), 10 p.
4. Bil JP, Hoornenborg E, Prins M, Hogewoning A, Dias Goncalves Lima F, de Vries HJC, Davidovich U. The Acceptability of Pre-Exposure Prophylaxis: Beliefs of Health-Care Professionals Working in Sexually Transmitted Infections Clinics and HIV Treatment Centers. Front Public Health. 2018 Feb 9;6:5.
5. Bil JP, Schrooders PA, Prins M, Kouw PM, Klomp JH, Scholing M, Huijbregts LP, Sonder GJ, Waegemaekers TC, de Vries HJ, Meijer W, Zuure FR, Tostmann A. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015. Euro Surveill. 2018 Mar;23(11).
6. J.P. Bil, M. Prins, I. Fakoya, A. Volny-Anne, K.A. Burns, F.R. Zuure. Usage of purchased self-tests for HIV infections among migrants living in the UK, France and the Netherlands: a cross-sectional study. Sexually Transmitted Infections; (2018), 4 p.
7. W.P.H. van Bilsen, H.L. Zaaijer, A. Matser, K. van den Hurk, E. Slot, M.F. Schim van der Loeff, M. Prins, T.J.W. van de Laar . Infection pressure in men who have sex with men and their suitability to donate blood. Clinical Infectious Diseases; nr. ciy596 (2018)
8. A. Boerekamps, A.M. Newsum, C. Smit, [et al.]. High treatment uptake in human immunodeficiency virus/hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in The Netherlands. Clinical Infectous Diseases; volume 66 nr. 9 (2018), 1352-1359
9. Cole JH, Caan MWA, Underwood J, De Francesco D, van Zoest RA, Wit FWNM, Mutsaerts HJMM, Leech R, Geurtsen GJ, Portegies P, Majoie CBLM, Schim van der Loeff MF, Sabin CA, Reiss P, Winston A, Sharp DJ; COBRA collaboration.No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project. Clin Infect Dis. 2018 Jan 4.
10. D. De Francesco, F.W. Wit, J.H. Cole, M. Prins, [et al.]. The ‘COmorBidity in Relation to AIDS’ (COBRA) cohort : design, methods and participant characteristics. PLoS ONE; volume 13 nr. 3 (2018), e0191791
11. De Francesco, S.O. Verboeket, J. Underwood, E. Bagkeris, F.W. Wit, [et al.]. Patterns of co-occurring comorbidities in people living with hiv. Open Forum Infectious Diseases; volume 5 nr. 11 (2018), p. ofy272
12. M. Dijkstra, R.H.W. van Lunsen, K.W. Kooij, U. Davidovich, R.A. van Zoest, F.W.N.M. Wit, M. Prins, Reiss, M.F. Schim van der Loeff. HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy. AIDS; volume 32 nr. 9 (2018), 1137-1146
13. Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K; InC3 Collaborative. The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative. Clin Infect Dis. 2018 Jan 6;66(1):20-28.
14. I. Fakoya, D. Alvarez-Del Arco, M. Prins, [et al.]. HIV testing history and access to treatment among migrants living with HIV in Europe. Journal of the International AIDS Society; volume 21 nr. S4 (2018), 60-73
15. Hananta IPY, van Dam AP, Schim van der Loeff MF, Dierdorp M, Wind CM, Soebono H, de Vries HJC, Bruisten SM. Molecular epidemiology of Neisseria gonorrhoeae strains circulating in Indonesia using multi-locus variable number tandem repeat analysis (MLVA) and Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) techniques. BMC Infect Dis. 2018 Jan 5;18(1):7.
16. I.P.Y. Hananta, H.J.C. de Vries, A.P. van Dam, M.S. van Rooijen, H. Soebono, M.F. Schim van der Loeff. Spontaneous clearance of pharyngeal gonococcal infections: a retrospective study in patients of the Sexually Transmitted Infections Clinic; Amsterdam, the Netherlands; 2012 to 2015. Sexually Transmitted Diseases; volume 45 nr. 9 (2018), 549-599
17. L. Hartog, M.S. van Rooijen, J.K. Ujcic-Voortman, M. Prins, I.G.M. van Valkengoed. Ethnic differences in infectious burden and the association with metabolic risk factors for cardiovascular disease : a cross-sectional analysis. BMC Public Health; volume 18 (2018), 9 p.
18. Helm JJ van der, Koekenbier RH, van Rooijen MS, Schim van der Loeff MF, de Vries HJC. What Is the Optimal Time to Retest Patients With a Urogenital Chlamydia Infection? A Randomized Controlled Trial. Sex Transm Dis. 2018 Feb;45(2):132-137
19. A.D. Hintaran, S.J. Kliffen, W. Lodder, R. Pijnacker, D. Brandwagt, A.K. van der Bij, E.C. Siedenburg, G.J. Sonder, E.B. Fanoy, R. Joosten. Infection risks of city canal swimming events in the Netherlands in 2016. PLoS One; volume 13 nr. 7 (2018), 16 p.
20. E. Hoornenborg, L. Coyer, A. van Laarhoven, R.C.A. Achterbergh, H.J.C. de Vries, M. Prins, M.F. Schim van der Loeff. Change in sexual risk behaviour after six months of pre-exposure prophylaxis use : results from the Amsterdam pre-exposure prophylaxis demonstration project. AIDS; volume 32 nr. 11 (2018), 1527-1532
21. E. Hoornenborg, R.C.A. Achterbergh, M.F. Schim van der Loeff, U. Davidovich, J.J. van der Helm, A.A. Hogewoning, Y.T.H.P. van Duijnhoven, G.J.B. Sonder, H.J.C. de Vries, M. Prins. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis : baseline analysis of a demonstration study in Amsterdam. Journal of the International AIDS Society; volume 21 nr. 3 (2018), 11 p.
22. E. Hoornenborg, M. Prins, J.M. Prins, G.J. de Bree. Wild-type HIV infection despite PrEP: a lot to learn from a case report – Authors’ reply. The Lancet HIV; volume 5 nr. 1 (2018), e10-e11
23. Houdt R van, Ma B, Bruisten SM, Speksnijder AGCL, Ravel J, de Vries HJC. Lactobacillus iners-dominated vaginal microbiota is associated with increased susceptibility to Chlamydia trachomatis infection in Dutch women: a case-control study. Sex Transm Infect 2018;94:117-123.
24. S.H. Hulstein, A. Matser, C.J. Alberts, M.B. Snijder, M. Willhauck-Fleckenstein, K. Hufnagel, M. Prins, H.J.C. de Vries, M.F. Schim van der Loeff, T. Waterboer. Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) study. BMC Infectious Diseases; volume 18 nr. 612 (2018), 11 p.
25. S.H. Hulstein, E. Hoornenborg, M.F. Schim van der Loeff. Error in the calculation of person-time in the before-PrEP period by Beymer et al. Sexually Transmitted Infections; volume 94 nr. 7 (2018), p. 514
26. I. Jarrin, S. Monge, A. Mocroft, M. Prins, [et al.] ; Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?. HIV Medicine; volume 19 nr. 1 (2018), 42-48
27. F.A.E. Lambers, W. van der Veldt, M. Prins, U. Davidovich. Changing the odds: motives for and barriers to reducing HCV-related sexual risk behaviour among HIV-infected MSM previously infected with HCV. BMC Infectious Diseases; volume 2018 nr. 18: 678 (2018), 11 p.
28. S. Lauriks, M.C.A. Buster, M.A.S. de Wit, O.A. Arah, A.W. Hoogendoorn, J. Peen, N.S. Klazinga; Validity of police contacts as a performance indicator for the public mental health care system in Amsterdam : an open cohort study.  Social Psychiatry and Psychiatric Epidemiology ; volume 53, p. 577-586
29. T.C. Lin, M. Dijkstra, G.J. de Bree, M.F. Schim van der Loeff, M. Hoeningl. Brief report : The Amsterdam symptom and risk-based score predicts for acute hiv infection in men who have sex with men in San Diego. Journal of Acquired Immune Deficiency Syndromes; volume 79 nr. 2 (2018), e52-e55
30. Marra E, Berkhof J, de Vries HJC en Schim van der Loeff MF. Is vaccinatie van jongens of mannen tegen HPV zinvol? NTvG 2018:162:D1200.
31. Marra E, King A, van Logchem E, van der Weele P, Mooij SH, Heijman T, Meijer CJLM, Verhagen DWM, van der Sande MAB, Schim van der Loeff MF. Anal HPV 16 and 18 viral load: A comparison between HIV-negative and -positive MSM and association with persistence. J Med Virol. 2018 Jan;90(1):76-83.
32. Marra E, Kroone N, Freriks E, van Dam CL, Alberts CJ, Hogewoning AA, Bruisten S, van Dijk A, Kroone MM, Waterboer T, Schim van der Loeff MF. Vaginal and anal human papillomavirus infection and seropositivity among female sex workers in Amsterdam, the Netherlands: Prevalence, concordance and risk factors. J Infect. Vol 76, 4, April 2018, 393-405
33. A.A. Matser, M.F. Schim van der Loeff, R.B. Geskus. Determining the most likely source of infection : an application to neisseria gonorrhoeae among men who have sex with men. Epidemiology; volume 29 nr. 3 (2018), 421-430
34. K.H. Mayer, H.J.C. de Vries. HIV and sexually transmitted infections : responding to the “newest normal”.. Journal of the International AIDS Society; volume 21 nr. 7 (2018), e25164
35. Menezes LJ, Pokharel U, Sudenga SL, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim van der Loeff MF, van der Laan LE, Kipping S, Taylor D, Giuliano AR. Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial. Sex Transm Infect 2018;94:55–61
36. Merat SJ, van de Berg D, Bru C, Yasuda E, Breij E, Koostra N, Prins M, Molenkamp R, Bakker AQ, de Jong MD, Spits H, Schinkel J, Beaumont T. Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus.. Journal of Immunological Methods Volume 454, March 2018, Pages 15-26.
37. Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? HIV Med. 2018 vol. 19 issue 1 p. 42-48
38. A.M. Newsum, R. Molenkamp, J.T. van der Meer, S.P. Rebers, M. Prins, M. van der Valk, J. Schinkel. Persistence of NS5B-S282T, a sofosbuvir resistance-associated substitution, in a HIV/HCV-coinfected MSM with risk of onward transmission. Journal of Hepatology; volume 69 (2018), p. 966-970
39. A.M. Newsum, M.S. van Rooijen, M. Kroone, S.M. Bruisten, A. Matser, A. Hogewoning, M. Prins, T.L.J. Heijman. Stable low hepatitis C virus antibody prevalence among HIV-negative MSM attending the STI outpatient clinic in Amsterdam, 2007 – 2017. Sexually Transmitted Diseases; (2018)
40. A.D. Olson, N. Bannert, M. Prins, [et al.]. Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort. AIDS; volume 32 nr. 2 (2018), 161-169
41. Overbosch FW, Schinkel J, Stolte IG, Prins M, Sonder GJB. Dengue virus infection among long-term travelers from the Netherlands: A prospective study, 2008-2011. PLoS One. 2018 Feb 7;13(2):e0192193
42. T. Reyniers, B. Vuylsteke, B. Pirotte, E. Hoornenborg, J.P. Bil, K. Wouters, M. Laga, C. Nöstlinger. Physicians’ preparedness for pre-exposure prophylaxis: results of an online survey in Belgium. Sexual Health; volume 15 (2018), p. 606-611
43. C.H. Roberts, S. Ouburg, M.D. Preston, H.J.C. de Vries, M.J. Holland, S.A. Morré. Pathway-wide genetic risks in chlamydial infections overlap between tissue tropisms : a genome-wide association scan. Mediators of Inflammation; volume 2018 (2018), 9 p.
44. C. Rodrigo, P. Leung, A.R. Lloyd, J. Schinkel, M. Prins, [et al.]. Genomic variability of within-host hepatitis C variants in acute infection. Journal of Viral Hepatitis; (2018), 9 p.
45. R. Sacks-Davis, J.S. Doyle, M. Prins, [et al.]. Linkage and retention in HCV care for HIV-infected populations : early data from the DAA era. Journal of  the  International  AIDS  Society; volume 21 nr. S2 (2018), e25051
46. D.K. van Santen, M.F. Schim van der Loeff, J. Cartier van Dissel, J.P.D. Martens, M. van der Valk, M. Prins. High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands. European Journal of Gastroenterology & Hepatology; volume 30 nr. 10 (2018), 1168-1176
47. M.F. Schim van der Loeff. Secondary anal cancer prevention in the HIV-infected : a step ahead but a long way to go. AIDS; volume 32 nr. 16 (2018), p. 2425–2427
48. Siegenbeek van Heukelom ML, Gosens KCM, Prins JM, de Vries HJC. Cryotherapy for Intra- and Perianal High-Grade Squamous Intraepithelial Lesions in HIV-Positive Men who have Sex with Men. Am J Clin Dermatol. February 2018, Volume 19, Issue 1,  pp 127–132
49. M.L. Siegenbeek van Heukelom, E. Marra, I. Cairo, A. van Eeden, M.F. Schim van der Loeff, H.J.C. de Vries, J.M. Prins. Detection rate of high-grade squamous intraepithelial lesions as a quality assurance metric for high-resolution anoscopy in HIV-positive men. Diseases of the Colon & Rectum; volume 61 nr. 6 (2018), 7 p.
50. V. Smelov, A. Vrbanac, H.J.C. de Vries, [et al.]. Chlamydia trachomatis strain types have diversified regionally and globally with evidence for recombination across geographic divides. Frontiers in Microbiology; volume 8 nr. 2195 (2018), 14 p.
51. Steba GS, Koekkoek SM, Vanhommerig JW, Brinkman K, Kwa D, Van Der Meer JTM, Prins M, Berkhout B, Tanck M, Paxton WA, Molenkamp R, Schinkel J; MSM Observational Study of Acute Infection with Hepatitis C (MOSAIC) Study Group and Amsterdam Cohort Studies (ACS). DC-SIGN Polymorphisms Associate with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users. DC-SIGN Polymorphisms Associate with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users. J Infect Dis. 2018 Jan 17;217(3):353-357.
52. G.S. Steba, J.W. Vanhommerig, M. Prins, [et al.]. SNP rs688 within the low-density lipoprotein receptor (LDL-R) gene associates with HCV susceptibility. Liver International; (2018), 7 p.
53. O.T. Stirrup, A.J. Copas, R.B. Geskus, [et al.]. Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion. HIV Medicine; volume 19 (2018), 184-194
54. M. Strouhal, L. Mikalová, S.M. Bruisten, [et al.]. Complete genome sequences of two strains of treponema pallidum subsp. pertenue from Indonesia: modular structure of several treponemal genes. PLOS Neglected Tropical Diseases; (2018), 20 p.
55. D.E. Twisk, M.A.B. van der Sande, A. van Eeden, D.A.M. Heideman, F.R.M. van der Klis, H.J.C. de Vries, M.F. Schim van der Loeff. Detection of incident anal high-risk HPV-DNA in MSM : incidence or reactivation?. The Journal of Infectious Diseases; volume 218 nr. 7 (2018), 1018-1026
56. C. van der Veer, R. van Houdt, A. van Dam, H.J.C. de Vries, S.M. Bruisten. Accuracy of a commercial multiplex PCR for the diagnosis of bacterial vaginosis. Journal of Medical Microbiology; volume 67 (2018), 1265-1270
57. B. Versteeg, L.J. van den Broek, S.M. Bruisten, M. Mullender, H.J.C. de Vries, S. Gibbs. An organotypic reconstructed human urethra to study chlamydia trachomatis infection. Tissue Engineering Part A; (2018) B. Versteeg, S.M. Bruisten, Y. Pannekoek, [et al.]. Genomic analyses of the chlamydia trachomatis core genome show an association between chromosomal genome, plasmid type and disease. BMC Genomics; volume 19 nr. 130 (2018), 13
58. H.J.C. de Vries, R.D.M. Steenbergen. The effect of ART on cervical cancer precursor lesions. Lancet HIV; volume 5 nr. 1 (2018), e6-e8
59. H.J.C. de Vries, M. Soltanjoor, S. Kezic, C.E. Vergunst. Sinecatechins ointment 10% (Veregen®) for genital warts: percutaneous penetration of epigallocatechin gallate concentrations in the stratum corneum collected by adhesive tape stripping method. Journal of the European Academy of Dermatology and Venereology; volume 32 (2018), e358-e369

2017

1. Achterbergh R, van der Helm JJ, van den Boom W, Heijman T, Stolte IG, van Rooijen MS, de Vries H. Is rectal douching and sharing douching equipment associated with anorectal chlamydia and gonorrhoea? A cross-sectional study among men who have sex with men. Sex Transm Infect. 2017 vol. 93 p. 431-437
2. Achterbergh RCA, van der Helm JJ, van den Brink W, de Vries HJC. Design of a syndemic based intervention to facilitate care for men who have sex with men with high risk behaviour: the syn.bas.in randomized controlled trial. BMC Infect Dis. 2017 Jun 6;17(1):398.
3. Achterbergh RCA, Bruisten SM, V D Laar TJW, van der Weijden CP, Scholing M, Cornelissen M, de Vries HJC. An HIV-negative Same-sex Male Couple Both Infected With Hepatitis C Virus. Acta Derm Venereol. 2017 Nov 15;97(10):1255-1257
4. Alberts CJ, van der Loeff MF, Hazeveld Y, de Melker HE, van der Wal MF, Nielen A, El Fakiri F, Prins M, Paulussen TG. A longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands. BMC Public Health. 2017 Feb 21;17(1):220.
5. Alberts CJ, Michel A, Bruisten S, Snijder MB, Prins M, Waterboer T, Schim van der Loeff MF. High-risk human papillomavirus seroprevalence in men and women of six different ethnicities in Amsterdam, the Netherlands: The HELIUS study. Papillomavirus Res. 2017 Jun;3:57-65.
6. Bartelsman M, Joore IK, van Bergen JE, Hogewoning AA, Zuure FR, van Veen MG; HIV Transmission Elimination AMsterdam (H-TEAM) initiative. HIV testing week 2015: lowering barriers for HIV testing among high-risk groups in Amsterdam. BMC Infect Dis. 2017 Aug 1;17(1):529. https://doi.org/10.1186/s12879-017-2617-0
7. Bartelsman M, Vaughan K, van Rooijen MS, de Vries HJC, Xiridou M. Impact of point-of care management on the transmission of anogenital gonococcal infections among men who have sex with men in Amsterdam: a mathematical modelling and cost-effectiveness study. Sex Transm Infect. 2017 Sep 23. pii: sextrans-2017-053159.
8. Bil JP, Prins M, Stolte IG, Dijkshoorn H, Heijman T, Snijder MB, Davidovich U, Zuure FR. Usage of purchased self-tests for HIV and sexually transmitted infections in Amsterdam, the Netherlands: results of population-based and serial cross-sectional studies amongthe general population and sexual risk groups. BMJ Open. 2017 Sep 21;7(9):e016609.
9. Booiman T, Wit FW, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Garagnani P, Pirazzini C, Franceschi C, Fuchs D, Gisslén M, Winston A, Reiss P, Kootstra NA; Comorbidity in Relation to AIDS (COBRA) Collaboration. High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid. Open Forum Infect Dis. 2017 May 25;4(3):ofx108. https://doi.org/10.1093/ofid/ofx108.
10. Booiman T, Wit FW, Girigorie AF, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Franceschi C, Deeks SG, Winston A, Reiss P, Kootstra NA; Co-morBidity inRelation to Aids (COBRA) Collaboration. Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART andlifestyle matched controls. PLoS One. 2017 Aug 14;12(8):e0183357.
11. Borgdorff H, van der Veer C, van Houdt R, Alberts CJ, de Vries HJ, Bruisten SM, Snijder MB, Prins M, Geerlings SE, Schim van der Loeff MF, van de Wijgert JHHM. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLoS One. 2017 Jul 11;12(7):e0181135.
12. Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d’Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. HIV Med. 2017 Jan;18(1):33-44.
13. Cole JH, Underwood J, Caan MW, De Francesco D, van Zoest RA, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CB, Winston A, Reiss P, Sharp DJ; COBRA collaboration. Increased brain-predicted aging in treated HIV disease. Neurology. 2017 Apr 4;88(14):1349-1357.
14. Coleman R, Prins M. Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe (editorial). Eurosurveillance 2017 Oct;22(47)
15. de Gier B, Suryapranata FS, Croughs M, van Genderen PJ, Keuter M, Visser LG, van Vugt M, Sonder GJ. Increase in imported malaria in the Netherlands in asylum seekers and VFR travellers. Malar J. 2017 Feb 2;16(1):60.
16. de Vries HJC, Baral S. Assessing the health and well-being of gay, bisexual and other men who have sex with men around the world. Sex Transm Infect. 2017 Aug;93(5):303-304.
17. de Vrieze NHN, Versteeg B, Bruisten SM, van Rooijen MS, van der Helm JJ, de Vries HJC. Low Prevalence of Urethral Lymphogranuloma Venereum Infections Among Men Who Have Sex With Men: A Prospective Observational Study, Sexually Transmitted Infection Clinic in Amsterdam, the Netherlands. Sex Transm Dis. 2017 Sep;44(9):547-550.
18. Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, Cole M, Seah C, Trembizki E, Trees DL, Kersh EN, Abrams AJ, de Vries HJ, van Dam AP, Medina I, Bharat A, Mulvey MR, Van Domselaar G, Martin I. Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR): a novel antimicrobial resistance multilocus typing scheme for tracking the global dissemination of N. gonorrhoeae strains. J Clin Microbiol. 2017 May;55(5):1454-1468.
19. Dijkstra M, de Bree GJ, Stolte IG, Davidovich U, Sanders EJ, Prins M, Schim van der Loeff MF. Development and validation of a risk score to assist screening for acute HIV-1 infection among men who have sex with men. BMC Infect Dis. 2017 Jun 14;17(1):425. https://dx.doi.org/10.1186%2Fs12879-017-2508-4
20. Drückler S, van Rooijen MS, de Vries HJC. Chemsex among men who have sex with men: a sexualized drug use survey among clients of the sexually transmittted infection outpatient clinic and users of a gay dating app in Amsterdam, the Netherlands. SexTransm Dis 2017 Oct.
21. Dukers NHTM, van Rooijen MS, Hogewoning A, van Liere GAFS, Steenbakkers M, Hoebe CJPA. Incidence of repeat testing and diagnoses of Chlamydia trachomatis and Neisseria gonorrhoea in swingers, homosexual and heterosexual men and women at two large Dutch STI clinics, 2006-2013. Sex Transm Infect. 2017; 93: p. 383–389
22. Eltahla AA, Rodrigo C, Betz-Stablein B, Grebely J, Applegate T, Luciani F, Schinkel J, Dore GJ, Page K, Bruneau J, Morris MD, Cox AL, Kim AY, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Lloyd AR, Bull RA; InC3 Study Group. Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents. J Viral Hepat. 2017 Jan;24(1):37-42.
23. European Union HCV Collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. Lancet Gastroenterol Hepatol. 2017 May;2(5):325-336.
24. Fakoya I, Álvarez-Del Arco D, Copas AJ, Teixeira B, Block K, Gennotte AF, Volny-Anne A, Bil JP, Touloumi G, Del Amo J, Burns FM. Factors Associated With Access to HIV Testing and Primary Care Among Migrants Living in Europe: Cross-Sectional Survey. JMIR Public Health Surveill. 2017 Nov 6;3(4):e84.
25. Franse CB, Kayigamba FR, Bakker MI, Mugisha V, Bagiruwigize E, Mitchell KR, Asiimwe A, Schim van der Loeff MF. Linkage to HIV care before and after the introduction of provider-initiated testing and counselling in six Rwandan health facilities. AIDS Care. 2017 Mar;29(3):326-334.
26. Freidl GS, Sonder GJ, Bovée LP, Friesema IH, van Rijckevorsel GG, Ruijs WL, van Schie F, Siedenburg EC, Yang JY, Vennema H. Hepatitis A outbreak among men who have sex with men (MSM) predominantly linked with the EuroPride, the Netherlands, July 2016 to February 2017. Euro Surveill. 2017 Feb 23;22(8). pii: 30468.
27. Grijsen ML, de Vries HJC. Kerion. CMAJ. 2017 May 23;189(20):E725.
28. Hananta IPY, van Dam AP, Bruisten SM, Schim van der Loeff MF, Soebono H, de Vries HJC. Value of light microscopy to diagnose urogenital gonorrhoea: a diagnostic test study in Indonesian clinic-based and outreach sexually transmitted infections services. BMJ Open. 2017 Aug 11;7(8):e016202.
29. Hananta IPY, De Vries HJC, van Dam AP, van Rooijen MS, Soebono H, Schim van der Loeff MF. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study. Sex Transm Infect. 2017 Aug 19. pii: sextrans-2017-053147.
30. Heijman T, Zuure F, Stolte I, Davidovich U. Motives and barriers to safer sex and regular STI testing among MSM soon after HIV diagnosis. BMC Infectious Diseases BMC Infect Dis. 2017 Mar 7;17(1):194.
31. Hoornenborg E, Achterbergh RCA, Schim Van Der Loeff MF, Davidovich U, Hogewoning A, Vries HJC, Schinkel J, Prins M, Laar TJWV, on behalf of the Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative, MOSAIC study group. MSM starting pre-exposure prophylaxis (PrEP) are at risk of HCV infection. AIDS 2017 Jul 17;31(11):1603-1610.
32. Hoornenborg E, Krakower DS, Prins M, Mayer KH. Preexposure prophylaxis for men who have sex with men and transgender persons in early adopting countries: a narrative review. AIDS. 2017 Aug 28.
33. Jehee I, van der Veer C, Himschoot M, Hermans M, Bruisten S. Direct detection of Trichomonas vaginalis virus in Trichomonas vaginalis positive clinical samples from the Netherlands. J Virol Methods. 2017 Sep 13;250:1-5.
34. Joosten R, Sonder G, Parkkali S, Brandwagt D, Fanoy E, Mughini-Gras L, Lodder W, Ruland E, Siedenburg E, Kliffen S, van Pelt W. Risk factors for gastroenteritis associated with canal swimming in two cities in the Netherlands during the summer of 2015: A prospective study. PLoS One. 2017 Apr 3;12(4):e0174732.
35. Kooij KW, Vogt L, Wit FWNM, van der Valk M, van Zoest RA, Goorhuis A, Prins M, Post FA, Reiss P; AGEhIV Cohort Study. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. J InfectDis. 2017 Sep 15;216(6):622-631.
36. Mangen MJ, Stibbe H, Urbanus A, Siedenburg EC, Waldhober Q, de Wit GA, van Steenbergen JE; National Working Group of hepatitis B behavioural risk-groups vaccination program. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile. Vaccine. 2017 May 31;35(24):3215-3221. .
37. Marra E, van Dam L, Kroone N, Craanen M, Zimet GD, Heijman T, Hogewoning AA, Sonder GJB, de Vries HJC, Alberts CJ, Paulussen TGWM, Schim van der Loeff MF. Determinants of Human Papillomavirus Vaccination Intention Among Female Sex Workers in Amsterdam, the Netherlands. Sex Transm Dis. 2017 44(12):756–762.
38. Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY,Lauer GM, Lloyd A,Rice T,Shoukry N, Maher L, Page K; for the International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3). Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Clin Infect Dis. 2017 Apr 1;64(7):860-869.
39. Newsum AM, Ho CK, Lieveld FI, van de Laar TJ, Koekkoek SM, Rebers SP, van der Meer JT, Wensing AM, Boland GJ, Arends JE, van Erpecum KJ, Prins M, Molenkamp R, Schinkel J. The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands. AIDS. 2017 Jan 2;31(1):105-112.
40. Newsum AM, Stolte IG, van der Meer JT, Schinkel J, van der Valk M, Vanhommerig JW, Buvé A, Danta M, Hogewoning A, Prins M; MOSAIC (MSM). Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM). Euro Surveill. 2017 May 25;22(21). pii: 30540.
41. Newsum AM, Schinkel J, van de Laar TJW, van der Meer JTM, Prins M. Spontaneous clearance of Hepatitis C virus infection among Human ImmunodeficiencyVirus-Infected men who sex with men (brief report). Open Forum Infectious Diseases, Volume 4, Issue 2, 1 April 2017, ofx090.
42. Prins M, Bruneau J. Estimates are not enough: scaling-up interventions to improve the health of people who inject drugs. Lancet Glob Health 2017 Dec;5(12):e1162-e1163.
43. Reyniers T, Hoornenborg E, Vuylsteke B, Wouters K, Laga M. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool. Sex Transm Infect. 2017 Aug;93(5):363-367.
44. Rodrigo C, Eltahla AA, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Shoukry NH, Lauer GM, Maher L, Schinkel J, Prins M, Hellard M, Lloyd AR; InC3 Collaborative. Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study. J Viral Hepat. 2017 Jan;24(1):43-52.
45. Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA; InC3 Study Group. Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection. Infect Infect Genet Evol. 2017 Jan 5;49:88-96.
46. van Santen DK, van der Helm JJ, Del Amo J, Meyer L, D’Arminio Monforte A, Price M, Béguelin CA, Zangerle R, Sannes M, Porter K, Geskus RB, Prins M; CASCADE Collaboration in EuroCoord. Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014. J Hepatol. olume 67, Issue 2, August 2017, Pages 255-262.
47. van Santen DK, van der Helm JJ, Lindenburg K, Schim van der Loeff M, Prins M. HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015. Int J Drug Policy. Volume 47, September 2017, Pages 95-10
48. Seth-Smith HM, Galán JC, Goldenberger D, Lewis DA, Peuchant O, Bébéar C, de Barbeyrac B, Bénard A, Carter I, Kok J, Bruisten SM, Versteeg B, Morré SA, Thomson NR, Egli A, de Vries HJ. Concern regarding the alleged spread of hypervirulent lymphogranuloma venereum Chlamydia trachomatis strain in Europe. Euro Surveill. 2017 Apr 13;22(15). pii: 30511.
49. Siegenbeek van Heukelom ML, Marra E, de Vries HJC, Schim van der Loeff MF, Prins JM. Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible? AIDS. 2017 Oct 23;31(16):2295-2301.
50. Smelov V, Vrbanac A, van Ess EF, Noz MP, Wan R, Eklund C, Morgan T, Shrier LA, Sanders B, Dillner J, de Vries HJC, Morre SA, Dean D. Chlamydia trachomatis Strain Types Have Diversified Regionally and Globally with Evidence for Recombination across Geographic Divides. Front Microbiol. 2017 Nov 13;8:2195
51. Strouhal M, Mikalová L, Havlíčková P, Tenti P, Čejková D, Rychlík I, Bruisten S, Šmajs D. Complete genome sequences of two strains of Treponema pallidum subsp. pertenue from Ghana, Africa: Identical genome sequences in samples isolated more than 7 years apart. PLoS Negl Trop Dis. 2017 Sep 8;11(9):e0005894.
52. Su T, Mutsaerts HJ, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB; AGEhIV Cohort Study. Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. AIDS. 2017 Mar 27;31(6):847-856.
53. Sudenga SL, Torres BN, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim Van der Loeff MF, Van der Laan LE, Kipping S, Taylor D, Giuliano AR. HPV serostatus pre- and post-vaccination in a randomized phase ii preparedness trial among young western cape, South African women: the evri trial.  Papillomavirus Res. 2017 Jun;3:50-56.
54. Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, Marrazzo JM, Sonder GJB, Schwebke JR, Hoornenborg E, Peeling RW, Philip SS, Low N, Fairley CK. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. Volume 17, Issue 8, August 2017, Pages e235-e279
55. Vanhommerig JW, Bezemer D, Molenkamp R, Van Sighem AI, Smit C, Arends JE, Lauw FN, Brinkman K, Rijnders BJ, Newsum AM, Bruisten SM, Prins M, Van Der Meer JT, Van De Laar TJ, Schinkel J; MOSAIC study and the ATHENA national observational cohort. Limited overlap between phylogenetic HIV and HCV clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM. AIDS. AIDS. 31(15):2147–2158, SEP 2017
56. Veer C van der, Bruisten SM, van der Helm JJ, de Vries HJ, van Houdt R. The Cervicovaginal Microbiota in Women Notified for Chlamydia trachomatis Infection: A Case-Control Study at the Sexually Transmitted Infection Outpatient Clinic in Amsterdam, The Netherlands. Clin Infect Dis. 2017 Jan 1;64(1):24-31.
57. Versteeg B, Bruisten SM, Heijman T, Vermeulen W, van Rooijen MS, van Dam AP, Schim van der Loeff MF, de Vries HJC, Scholing M. Monitoring therapy success of urogenital Chlamydia trachomatis infections in women: A prospective observational cohort study. PLoS One. 2017 Sep 21;12(9):e0185295.
58. Visser M, Heijne JCM, Hogewoning AA, van Aar F. Frequency and determinants of consistent STI/HIV testing among men who have sex with men testing at STI outpatient clinics in the Netherlands: a longitudinal study. Sex Transm Infect. 2017 Sep;93(6):396.
59. Wagemakers A, Jahfari S, de Wever B, Spanjaard L, Starink MV, de Vries HJ, Sprong H, Hovius JW. Borrelia miyamotoi in vectors and hosts in The Netherlands. Ticks Tick Borne Dis. 2017 Mar;8(3):370-374.
60. Wind CM, Schim van der Loeff MF, van Dam AP, de Vries HJ, van der Helm JJ. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015. Euro Surveill. 2017 Jan 5;22(1). pii: 30431.
61. Wind CM, de Vries E, Schim van der Loeff MF, van Rooijen MS, van Dam AP, Demczuk WH, Martin I, de Vries HJ. Decreased azithromycin susceptibility of Neisseria gonorrhoeae isolates in patients recently treated with azithromycin. Clin Infect Dis. 2017 Mar 24. [Epub ahead of print]
62. Wind CM, Bruisten SM, Schim van der Loeff MF, Dierdorp M, de Vries HJC, van Dam AP. A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015. Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02374-16.
63. Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Gätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valados E, Colin C, Friis-Moller N, Costagliola D, Thiebaut R, Chene G, and Matheron S, on behalf of the COHE in EuroCoord and ACHIeV2e Study Group. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study. J Antimicrob Chemother ;Volume 72, Issue 10, 1 October 2017, Pages 2869–2878
64. Woestenberg PJ, King AJ, van der Sande MA, Donken R, Leussink S, van der Klis FR, Hoebe CJ, Bogaards JA, van Benthem BH, Medical Microbiological Laboratories; Public Health Services. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors. J Infect 2017 Apr;74(4):393-400.
65. van Zoest RA, van der Valk M, Wit FW, Vaartjes I, Kooij KW, Hovius JW, Prins M, Reiss P; AGEhIV Cohort Study Group. Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy. Eur J Prev Cardiol. 2017 Aug;24(12):1297-1307.